IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?

被引:12
作者
Brugnano, R. [1 ]
Del Sordo, R. [2 ]
Covarelli, C. [2 ]
Gnappi, E. [3 ]
Pasquali, S. [3 ]
机构
[1] Osped S Maria Misericordia, Dept Nephrol & Dialysis, Piazza Menghini 1, I-06156 Perugia, Italy
[2] Univ Perugia, Sch Med, Dept Expt Med, Sect Pathol Anat & Histol, Perugia, Italy
[3] Santa Maria Nuova Hosp, UOC Nephrol & Dialysis, Reggio Emilia, Italy
关键词
IgM nephropathy; Minimal change disease; Focal segmental glomerulosclerosis; Nephrotic syndrome; Controversy; MESANGIAL PROLIFERATIVE GLOMERULONEPHRITIS; IMMUNOGLOBULIN-M NEPHROPATHY; IDIOPATHIC NEPHROTIC SYNDROME; GLOMERULAR-DISEASE; LONG-TERM; NATURAL-HISTORY; SINGLE-CENTER; FOLLOW-UP; DEPOSITS; CHILDREN;
D O I
10.1007/s40620-016-0269-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Immunoglobulin (Ig)M nephropathy (IgMN), known since 1978, is a very controversial clinicopathological entity characterized by IgM diffuse deposits in the mesangium at immunofluorescence whereas light microscop identifies minimal glomerular lesion, hypercellularity and expansion of the mesangium or sclerotic focal, segmental lesion. Clinically, it is a nephrotic syndrome, especially in pediatric patients, or asymptomatic proteinuria and/or isolated hematuria. These characteristics narrowly define IgMN between minimal change disease and focal segmental glomerulosclerosis, so it is not often recognized as a separate pathology. Homogeneous epidemiologic, pathogenetic, clinical or histological data are not available. Recent research on the pathogenetic role of mesangial IgM has, however, renewed interest in IgMN and naturally the controversies.
引用
收藏
页码:479 / 486
页数:8
相关论文
共 50 条
  • [31] Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis
    Eduardo H. Garin
    Jochen Reiser
    Gabriel Cara-Fuentes
    Changli Wei
    Dany Matar
    Heiman Wang
    Nada Alachkar
    Richard J. Johnson
    Pediatric Nephrology, 2015, 30 : 469 - 477
  • [32] TRPC6 Gene Variants in Czech Adult Patients with Focal Segmental Glomerulosclerosis and Minimal Change Disease
    Obeidova, L.
    Reiterova, J.
    Lnenicka, P.
    Stekrova, J.
    Safrankova, H.
    Kohoutova, M.
    Tesar, V.
    FOLIA BIOLOGICA, 2012, 58 (04) : 173 - 176
  • [33] Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis
    Panupong Hansrivijit
    Wisit Cheungpasitporn
    Charat Thongprayoon
    Nasrollah Ghahramani
    BMC Nephrology, 21
  • [34] Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis
    Hansrivijit, Panupong
    Cheungpasitporn, Wisit
    Thongprayoon, Charat
    Ghahramani, Nasrollah
    BMC NEPHROLOGY, 2020, 21 (01)
  • [35] Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria
    Agrawal, Vinita
    Prasad, Narayan
    Jain, Manoj
    Pandey, Rakesh
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (06) : 811 - 818
  • [36] Immunoglobulin G/albumin staining in tubular protein reabsorption droplets in minimal change disease and focal segmental glomerulosclerosis
    Bu, Lihong
    Mirocha, James
    Haas, Mark
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (06) : 1016 - 1022
  • [37] Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis
    Garin, Eduardo H.
    Reiser, Jochen
    Cara-Fuentes, Gabriel
    Wei, Changli
    Matar, Dany
    Wang, Heiman
    Alachkar, Nada
    Johnson, Richard J.
    PEDIATRIC NEPHROLOGY, 2015, 30 (03) : 469 - 477
  • [38] Nephrotic syndrome in minimal change disease (kidneys), focal segmental glomerulosclerosis and focal mesangioproliferative glomerulonephritis
    Voznesenskaya, TS
    Sergeeva, TV
    TERAPEVTICHESKII ARKHIV, 2002, 74 (06) : 31 - 33
  • [39] Minimal-Change-Disease (MCD) und fokal-segmentale GlomeruloskleroseMinimal change disease and focal segmental glomerulosclerosis
    Thomas Osterholt
    Thomas Benzing
    Paul Thomas Brinkkötter
    Die Nephrologie, 2025, 20 (1) : 18 - 25
  • [40] CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance: Response
    Cara-Fuentes, Gabriel
    Johnson, Richard J.
    Reiser, Jochen
    Garin, Eduardo H.
    PEDIATRIC NEPHROLOGY, 2014, 29 (08) : 1467 - 1468